Managing Acute Intermediate Risk Pulmonary Thromboembolism in a Patient Who Developed Heparin Induced Thrombocytopenia: Review of Current Guidelines and Literature

Autor:	Blerina Asllanaj, Elizabeth benge, Sapna Bhatia, Yi McWhorter
Rok vydání:	2022
DOI:	10.22541/au.166599046.69966119/v1
Popis:	Mortality rates for pulmonary embolism differ significantly, indicating a need for escalated management. Treatment options include systemic anticoagulation, catheter-directed thrombolysis and/or thrombectomy and surgical thrombectomy. Heparin-induced thrombocytopenia is a severe complication as a result of any form of heparin which limits pharmacologic therapy with thrombolytics and anticoagulation.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::216c83dc446bdc9b1c2ce99b2c7fce6b https://doi.org/10.22541/au.166599046.69966119/v1 Zobrazit plný text záznamu